Skip to main content
Clinical Trials/ISRCTN62859294
ISRCTN62859294
Completed
未知

A pilot study of the feasibility and patient-related outcomes of performing a walking intervention in patients undergoing treatment for rectal cancer (the REx trial)

HS Greater Glasgow and Clyde (UK)0 sites80 target enrollmentMarch 17, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
HS Greater Glasgow and Clyde (UK)
Enrollment
80
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30657249 feasibility results (added 21/01/2019) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32564236/ muscle mass results (added 22/06/2020)

Registry
who.int
Start Date
March 17, 2014
End Date
June 1, 2016
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HS Greater Glasgow and Clyde (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Any patient over 18 years of age
  • 2\. Independently mobile
  • 3\. Has been diagnosed with rectal cancer
  • 4\. Planned first line of treatment is chemotherapy and radiotherapy followed by curative surgery
  • (timing at discretion of surgeon, but expected between 10\-12 weeks post\-CRX)

Exclusion Criteria

  • 1\. Chemotherapy and radiotherapy not first\-line treatment
  • 2\. Patient has had previous malignancies
  • 3\. Significant co\-morbidity where inclusion into this trial would put the patient?s health at risk
  • 4\. Patient has any mental, physical or psychological impairment that prevents them from giving signed informed consent
  • 5\. Patient is already achieving their recommended activity level per week where participation in a walking programme would mean he/she would be exercising at a lower level than normal

Outcomes

Primary Outcomes

Not specified

Similar Trials